Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 93,456 shares at $16.94 ($1.6M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($1.6M) by President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $167K | — | Filing → |